A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma

NCT03840967 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Due to slow accruals

Conditions

Esophageal Cancer
Gastric Cancer
Adenocarcinoma

Interventions

DRUG: Niraparib

Sponsor

Shadia Jalal, MD

Collaborators

[object Object]
[object Object]